Icelandic Ísafjördur-based company Kerecis, which develops medical solutions to treat chronic wounds and abdominal wall reconstruction from fish skin, recently signed an investment agreement with seafood companies Klofningur and Hradfrystihúsid-Gunnvör.
Icelandic cod. Copyright: Icelandic Photo Agency.
The agreement includes continued expansion of Kerecis’s operations in Ísafjördur, the largest settlement in the West Fjords. Kerecis uses fish skin from farmed cod from Hradfrystihúsid-Gunnvör, which are treated by Klofningur and made suitable for further production, as stated on bb.is.
Mayor Daníel Jakobsson welcomed the agreement, saying this is good news for the Westfjordian economy. “We have prime circumstances here. I am very hopeful about this project and hope it will be successful. […] Gunnvör is a very important company in the municipality and I am especially pleased that these powerful companies have decided to invest in innovation.”
MariGen Wound. Courtesy of Kerecis.
Kerecis is working closely with companies in the healthcare sector on developing a technology called MariGen which can be used to repair tissue damages, and creams under the brand MariCell to treat skin problems.
The company’s products are based on patent pending technology that extracts proteins and lipids from fish skin.
Trial manufacturing of Kerecis’s products is about to begin and the company is working on relocating within Ísafjördur to new facilities at the Íshúsfélagshús.
